Pages that link to "Q42714345"
Jump to navigation
Jump to search
The following pages link to Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes (Q42714345):
Displaying 50 items.
- Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies (Q24318474) (← links)
- Activin A directs striatal projection neuron differentiation of human pluripotent stem cells (Q24324143) (← links)
- Functional Properties of Human Stem Cell-Derived Neurons in Health and Disease (Q26747622) (← links)
- Human induced pluripotent stem cells for monogenic disease modelling and therapy (Q26750393) (← links)
- Epigenetic Research of Neurodegenerative Disorders Using Patient iPSC-Based Models (Q26772307) (← links)
- An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs (Q26775122) (← links)
- Huntington's disease: the past, present, and future search for disease modifiers (Q26830039) (← links)
- Longitudinal measures of proteostasis in live neurons: features that determine fate in models of neurodegenerative disease (Q26865220) (← links)
- Modeling Huntington's disease with induced pluripotent stem cells (Q27004209) (← links)
- Neurodegenerative diseases in a dish: the promise of iPSC technology in disease modeling and therapeutic discovery (Q27025493) (← links)
- Cell-based screening: extracting meaning from complex data (Q27305816) (← links)
- The Wnt receptor Ryk reduces neuronal and cell survival capacity by repressing FOXO activity during the early phases of mutant huntingtin pathogenicity (Q27314681) (← links)
- Advances in Stem Cell Research- A Ray of Hope in Better Diagnosis and Prognosis in Neurodegenerative Diseases (Q28067160) (← links)
- Utility of Induced Pluripotent Stem Cells for the Study and Treatment of Genetic Diseases: Focus on Childhood Neurological Disorders (Q28080219) (← links)
- Systems biology of neurodegenerative diseases (Q28080741) (← links)
- Cell reprogramming and neuronal differentiation applied to neurodegenerative diseases: Focus on Parkinson's disease (Q28080770) (← links)
- Induced Pluripotent Stem Cell Models to Enable In Vitro Models for Screening in the Central Nervous System (Q28082668) (← links)
- A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington's disease (Q28389607) (← links)
- Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem Cells (Q28551899) (← links)
- Biological and medical applications of a brain-on-a-chip (Q28973613) (← links)
- Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons (Q30543660) (← links)
- Derivation of myogenic progenitors directly from human pluripotent stem cells using a sphere-based culture (Q30577387) (← links)
- Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines (Q30603966) (← links)
- In Vivo Roles of a Patient-Derived Induced Pluripotent Stem Cell Line (HD72-iPSC) in the YAC128 Model of Huntington's Disease. (Q33727646) (← links)
- Monomeric, oligomeric and polymeric proteins in huntington disease and other diseases of polyglutamine expansion (Q33788913) (← links)
- Use of Genetically Altered Stem Cells for the Treatment of Huntington's Disease (Q33788929) (← links)
- Oligonucleotide-based strategies to combat polyglutamine diseases (Q33791247) (← links)
- Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion (Q33878156) (← links)
- Induced Pluripotent Stem Cells: Global Research Trends (Q33914515) (← links)
- Sensory neurons do not induce motor neuron loss in a human stem cell model of spinal muscular atrophy (Q33940257) (← links)
- Back to the future: how human induced pluripotent stem cells will transform regenerative medicine (Q34037858) (← links)
- Polyglutamine-expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMA. (Q34270135) (← links)
- Inhibition of apoptosis blocks human motor neuron cell death in a stem cell model of spinal muscular atrophy (Q34314191) (← links)
- Opportunities and challenges of pluripotent stem cell neurodegenerative disease models (Q34353458) (← links)
- Investigating human disease using stem cell models (Q34431170) (← links)
- Generation of human striatal neurons by microRNA-dependent direct conversion of fibroblasts (Q34469252) (← links)
- Reversal of cellular phenotypes in neural cells derived from Huntington's disease monkey-induced pluripotent stem cells (Q34469493) (← links)
- Pluripotent stem cells: the last 10 years (Q34546417) (← links)
- Stem cells on the brain: modeling neurodevelopmental and neurodegenerative diseases using human induced pluripotent stem cells (Q34845881) (← links)
- Functions of huntingtin in germ layer specification and organogenesis (Q34965525) (← links)
- Downregulation of microRNA-9 in iPSC-derived neurons of FTD/ALS patients with TDP-43 mutations. (Q35021606) (← links)
- Stimulation of GABA-induced Ca2 influx enhances maturation of human induced pluripotent stem cell-derived neurons (Q35053840) (← links)
- Modeling human neurological disorders with induced pluripotent stem cells (Q35056065) (← links)
- Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease (Q35087066) (← links)
- A monoclonal antibody TrkB receptor agonist as a potential therapeutic for Huntington's disease (Q35087700) (← links)
- Phosphorylation of mutant huntingtin at serine 116 modulates neuronal toxicity (Q35088655) (← links)
- HD CAGnome: a search tool for huntingtin CAG repeat length-correlated genes (Q35153990) (← links)
- Chromosome substitution strain assessment of a Huntington's disease modifier locus (Q35214662) (← links)
- A time course analysis of the electrophysiological properties of neurons differentiated from human induced pluripotent stem cells (iPSCs). (Q35214817) (← links)
- A striatal-enriched intronic GPCR modulates huntingtin levels and toxicity (Q35214858) (← links)